SUMMARY Haemoglobin electrophoresis screening of 2341 infants from the oases of eastern Saudi Arabia, performed in an attempt to detect cases early and then to follow up and give better management to patients with sickle cell disease, showed 20% with S-trait and 43 with sickle cell disease (37 HbSS and 6 S-r°thalassaemia). On follow-up from birth (or from 3 months) for a mean of 31 years there was more morbidity and mortality than in matched Saudi Arab controls, but these rates were lower than for affected black infants in the US or Jamaica. Serial haemoglobin levels were 1 g/dl lower than for controls; height and weight increases were the same. Mean fetal haemoglobin level was 32% at 4-5 years. Half of a subsample of 23 cases had evidence of coexistent octhalassaemia which appeared to protect against functional asplenia, judged by the presence of Howell-Jolly bodies; however there was no difference in degree of anaemia or clinical course. Early screening is recommended for infants at risk for sickle cell disease, and comprehensive care should be given even if the infant has the less severe type.
There has been recent emphasis' on the need for prospective studies in sickle cell disease (SCD), especially in infancy and early childhood when morbidity and mortality rates are believed to be high. Several studiesl-3 indicate there is considerable serious illness and death during the first few years.
Homozygous sickle cell anaemia (HbSS) in Saudi Arabs from the oasis areas of the Eastern Province of the country is characterised by an associated unusually high level of fetal haemoglobin (HbF), and this is believed to account for the relatively mild clinical course.4-5 It was suggested recently that the HbSS in these people represents a useful model for what might be achieved if HbF production could be manipulated after birth,6 so a full understanding of the natural history of HbSS in Saudi Arabs is of interest. The present study was designed to complement and extend our understanding5 of the natural history of SCD in 270 Saudi Arab subjects of all ages. An overall review suggested there was a mild clinical course even in infancy, but early morbidity and mortality rates were not studied. A prospective study, based on early detection by means of screening all infants before significant morbidity or mortality occurs, is needed to evaluate the problem in infants and children.
We report here the results of such a study, which includes the clinical and haematological findings of the 43 SCD subjects (37 HbSS) identified by a screening programme and followed up for a mean of 3-1 years. We compare the patients with SCD with an Arab control group, and with reported findings in blacks. The screening programme also gives data on the frequencies of the haemoglobinopathies occurring in Saudi Arabs from the Qatif oasis area.
Subjects and methods
The (Table 3) . Fourteen of 42 patients with SCD were in hospital because of illness during the first 3 years, compared with 6 of the controls. The difference is not significant (P = 0 07), but the difference is significant if the 37 HbSS patients alone, of whom 14 were in hospital, are compared (P = 0 02). The first and second years of life appeared to be equally at risk for illness leading to admittance to hospital. All except 7 patients received antibiotics for illnesses treated in the outpatient clinic. Both the patients and controls were treated in the clinic with antibiotics for an average of 31 different illnesses during the first 3 years. Growth, in the infants with HbSS, as reflected by the mean weights and heights of 14 boys and 7 girls (all having satisfactory measurements at least to age 2 years) was not significantly different from that in controls (Figure) . Clinical assessment of development did not show any difference from the controls. Only 3 out of 27 infants with SCD who had chest x-rays had cardiac enlargement, compared with 1 out of 14 controls.
There were 2 deaths. One child, at age 25 months, had vomited for 6 hours and appeared severely ill with drowsiness, cold clammy skin, and pallor; he died 30 minutes after admission. The spleen was not enlarged; a single blood culture was negative, but septicaemia seemed likely on clinical grounds. The other fatal case, who died at age 35 months, had had diarrhoea and fever for 5 days without treatment, was greatly dehydrated, and was dead on arrival, probably from gastroenteritis.
Discussion
Serious complications and also functional asplenia, in blacks with SCD, are seen only after age 6 months,1 3 811 making it practical to screen during the first half year as well as at birth. Although we were unable to perform cord blood screening, which may be ideal, this was not a serious problem for this prospective study since patients were followed up from birth in hospital-delivered cases (three-quarters of all), and from about age 3 months in the remainder.
We had previously noted" the presence of an unusually high level of HbF (mean 22 to 26%) in Saudi Arabs (children and adults) with HbSS; the present study shows the presence of an even higher level during the first few years of life ( Table 2 ). The mean level of HbF of 32 % even after age 3 years is in striking contrast to that in most other populations. 1 12 In most other populations the HbF, even though falling more slowly after birth than normally, was generally less than 15 % by age 1 year and less than 9% by 3 12 This helps to explain the disparity in mortality during the first two years, reported as 13 % for Jamaicans,3 compared with none for Saudi Arabs (P = 0-04). It is, nevertheless, of concern if any proportion of patients are without splenic function.
In the present study there were 2 patients with either proved or presumed bacteraemia: one died shortly after admission and the other had successful treatment of the salmonellosis with antibiotics. Each was between 2 and 3 years of age. The fatal case had an unusually severe course during his second year, being in hospital three times for infections and once for a hypoplastic crisis. The control group suffered no deaths, and only 6 needed to be admitted to hospital, distinctly fewer than for the HbSS subjects.
We showed previously that there is a 34-fold increased risk (compared with the general population) of pneumococcal meningitis for the Saudi Arab HbSS subject considering all age groups.5 The importance of pneumococcal bacteraemia and meningitis in HbSS cases in the US is well known." [19] [20] Since there is good evidence21-22 for the efficacy of polyvalent pneumococcal vaccine in subjects aged at least 2 years, we began a vaccination programme, in 1978, using a 14-valent preparation (Pneumovax). Penicillin prophylaxis from age 6 months up to age 6 years has been recommended23 because of the crucial period before the pneumococcal vaccine is effective (less than 2 years) and also because of vaccine failures. The effectiveness of such prophylaxis, even when compliance is not a problem, is unproved; trials are in progress. 23 We have not used penicillin prophylactically, and thus far have had no vaccine failures in 118 cases (all ages).
It is worth stressing that early screening for SCD is important, and that continuous comprehensive care is required if early detection is to be of value. This is true even for the less severely affected subject such as the Saudi Arab child. It is evident that vigilance, family education, and a trial ofpneumococcal vaccine are all indicated.
